Rankings
▼
Calendar
CPRX
Catalyst Pharmaceuticals, Inc.
$3B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$3M
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-0.05
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$488,645
Balance Sheet
Total Assets
$42M
Total Liabilities
$2M
Stockholders' Equity
$39M
Cash & Equivalents
$14M
← FY 2016
All Quarters
Q1 2017 →
CPRX Q4 2016 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
